Herpes Simplex Epithelial and Stromal Keratitis: An Epidemiologic Update

Survey of Ophthalmology

Volumn 57, Issue 5, 2012, Pages 448-462

  Farooq, Asim V ^a   Shukla, Deepak ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Antiviral resistance; Corneal latency; Epidemiology; HSV keratitis; Infectious blindness; Surveillance; Vision losss

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; GLYCOPROTEIN D; HERPES SIMPLEX VACCINE; IDOXURIDINE; IVERMECTIN; STEROID;

ANTIVIRAL RESISTANCE; ARTICLE; BLINDNESS; CORNEA TRANSPLANTATION; DEVELOPED COUNTRY; DEVELOPING COUNTRY; HERPES SIMPLEX EPITHELIAL KERATITIS; HERPES SIMPLEX KERATITIS; HERPES SIMPLEX STROMAL KERATITIS; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; INCIDENCE; NONHUMAN; ONCHOCERCIASIS; PATHOPHYSIOLOGY; PENETRATING KERATOPLASTY; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SEROPREVALENCE; SYSTEMATIC REVIEW; VIRUS LATENCY; VIRUS TRANSMISSION; VISUAL IMPAIRMENT;

BLINDNESS; CORNEAL STROMA; DRUG RESISTANCE, VIRAL; EPITHELIUM, CORNEAL; HUMANS; INCIDENCE; KERATITIS, HERPETIC; POPULATION SURVEILLANCE; PREVALENCE; SIMPLEXVIRUS; WORLD HEALTH;

EID: 84865157180     PISSN: 00396257     EISSN: 18793304     Source Type: Journal    
DOI: 10.1016/j.survophthal.2012.01.005     Document Type: Article

References (103)

1. Akhtar J., Tiwari V., Oh M.-J., et al. HVEM and nectin-1 are the major mediators of herpes simplex virus 1 (HSV-1) entry into human conjunctival epithelium. Invest Ophthalmol Vis Sci 2008, 49:4026-4035.
2. Al-Yousuf N., Mavrikakis I., Mavrikakis E., et al. Penetrating keratoplasty: indications over a ten year period. Br J Ophthalmol 2004, 88:998-1001.
3. Ashaye A., Aimola A. Keratitis in children as seen in a tertiary hospital in Africa. J Natl Med Assoc 2008, 100:386-390.
4. Bacon T.H., Levin M.J., Leary J.J., et al. Herpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapy. Clin Microbiol Rev 2003, 16:114-128.
5. Beckingsdale P., Mavrikakis I., Al-Yousuf N., et al. Penetrating keratoplasty: outcomes from a corneal unit compared to national data. Br J Ophthalmol 2006, 90:728-731.
6. Bertke A.S., Patel A., Krause P.R. Herpes simplex virus latency-associated transcript sequence downstream of the promoter influences type-specific reactivation and viral neurotropism. J Virology 2007, 81:6605-6613.
7. Bettahi I., Nesburn A.B., Yoon S., et al. Protective immunity against ocular herpes infection and disease induced by highly immunogenic self-adjuvanting glycoprotein D lipopeptide vaccines. Invest Ophthalmol Vis Sci 2007, 48:4643-4653.
8. Branco F.J., Fraser N.W. Herpes simplex virus type 1 latency-associated transcript expression protects trigeminal ganglion neurons from apoptosis. J Virol 2005, 79:9019-9025.
9. Branco B.C., Gaudio P.A., Margolis T.P. Epidemiology and molecular analysis of herpes simplex keratitis requiring primary penetrating keratoplasty. Br J Ophthalmol 2004, 88:1285-1288.
10. Burton E.A., Hong C.S., Glorioso J.C. The stable 2.0-kilobase intron of the herpes simplex virus type 1 latency-associated transcript does not function as an antisense repressor of ICP0 in nonneuronal cells. J Virology 2003, 77:3516-3530.
11. Celum C., Levine R., Weaver M., et al. Genital herpes and human immunodeficiency virus: double trouble. Bull World Health Organ 2003, 82:447-453.
12. Centifanto-Fitzgerald Y.M., Yamaguchi T., Kaufman H.E., et al. Ocular disease pattern induced by herpes simplex virus is genetically determined by a specific region of viral DNA. J Exp Med 1982, 155:475-489.
13. Christophers J., Clayton J., Craske J., et al. Survey of resistance of herpes simplex virus to acyclovir in northwest England. Antimicrob Agents Chemother 1998, 42868-42872.
14. Corey L., Wald A. Maternal and neonatal herpes simplex virus infections. N Engl J Med 2009, 361:1376-1385.
15. Danve-Sztanek C., Aymard M., Thouvenot D., et al. Surveillance network for herpes simplex virus resistance to antiviral drugs: 3-year follow-up. J Clin Microbiol 2004, 42:242-249.
16. Dawson C.R., Togni B. Herpes simplex eye infections: clinical manifestations, pathogenesis and management. Surv Ophthalmol 1976, 21:121-135.
17. Dixit R., Tiwari V., Shukla D. Herpes simplex virus type 1 induces filopodia in differentiated P19 neural cells to facilitate viral spread. Neurosci Lett 2008, 440:113-118.
18. Dorrepaal S.J., Cao K.Y., Slomovic A.R. Indications for penetrating keratoplasty in a tertiary referral centre in Canada, 1996-2004. Can J Ophthalmol 2007, 42:244-250.
19. Duan R., de Vries R.D., Osterhaus A.D., et al. Acyclovir-resistant HSV-1 isolates from patients with herpetic keratitis. J Infect Dis 2008, 198:659-663.
20. Garcia D.D., Farjo Q., Musch D.C., et al. Effect of prophylactic oral acyclovir after penetrating keratoplasty for herpes simplex keratitis. Cornea 2007, 26:930-934.
21. Ghiasi H., Cai S., Perng G.C., et al. Both CD4+ and CD8+ T cells are involved in protection against HSV-1 induced corneal scarring. Br J Ophthalmol 2000, 84:408-412.
22. Gonzales C.A., Srinivasan M., Whitcher J.P., et al. Incidence of corneal ulceration in Madurai District, South India. Ophthalmic Epidemiol 1996, 3:159-166.
23. Gordon Y.J., Romanowski E., Araullo-Cruz T., McKnight J.L. HSV-1 corneal latency. Invest Ophthalmol Vis Sci 1991, 32:663-665.
24. Gupta R., Warren T., Wald A. Genital herpes. Lancet 2007, 370:2127-2137.
25. Halford W.P., Balliet J.W., Gebhardt B.M. Re-evaluating natural resistance to herpes simplex virus type 1. J Virology 2004, 78:10086-10095.
26. Hill J.M., Ball M.J., Neumann D.M., et al. The high prevalence of herpes simplex virus type 1 DNA in human trigeminal ganglia is not a function of age or gender. J Virology 2008, 82:8230-8234.
27. Hodge W.G., Margolis T.P. Herpes simplex virus keratitis among patients who are positive or negative for human immunodeficiency virus: an epidemiologic study. Ophthalmology 1997, 104:120-124.
28. Ibrahim Y.W., Boase D.L., Cree I.A. Epidemiologic characteristics, predisposing factors and microbiological profiles of infectious corneal ulcers: the Portsmouth Corneal Ulcer Study. Br J Ophthalmol 2009, 93:1319-1324.
29. Inoda S., Wakakura M., Hirata J., et al. Stromal keratitis and anterior uveitis due to herpes simplex virus type-2 in a young child. Jpn J Ophthalmol 2001, 45:618-621.
30. Jones C.A., Cunningham A.L. Vaccination strategies to prevent genital herpes and neonatal herpes simplex virus (HSV) disease. Herpes 2004, 11:12-17.
31. Kabra A., Lalitha P., Mahadevan K., et al. Herpes simplex keratitis and visual impairment: a case series. Indian J Ophthalmol 2006, 54:23-27.
32. Kaufman H.E., Azcuy A.M., Varnell E.D., et al. HSV-1 DNA in tears and saliva of normal adults. Invest Ophthalmol Vis Sci 2005, 46:241-247.
33. Kaye S., Choudhary A. Herpes simplex keratitis. Prog Retin Eye Res 2006, 25:355-380.
34. Kaye S.B., Baker K., Bonshek R., et al. Human herpesviruses in the cornea. Br J Ophthalmol 2000, 84:563-571.
35. Keadle T.L., Laycock K.A., Miller J.K., et al. Efficacy of a recombinant glycoprotein D subunit vaccine on the development of primary and recurrent ocular infection with herpes simplex virus type 1 in mice. J Infect Dis 1997, 176:331-338.
36. Kudo E., Shiota H., Naito T., et al. Polymorphisms of thymidine kinase gene in herpes simplex virus type 1: analysis of clinical isolates from herpetic keratitis patients and laboratory strains. J Med Virol 1998, 56:151-158.
37. Labetoulle M., Auquier P., Conrad H., et al. Incidence of herpes simplex virus keratitis in France. Ophthalmology 2005, 112:888-895.
38. Lairson D.R., Begley C.E., Reynolds T.F., et al. Prevention of herpes simplex virus eye disease: a cost-effectiveness analysis. Arch Ophthalmol 2003, 121:108-112.
39. Lamey P.J., Hyland P.L. Changing epidemiology of herpes simplex virus type 1 infections. Herpes 1999, 6:20-24.
40. Langenberg A.G., Corey L., Ashley R.L., et al. A prospective study of new infections with herpes simplex virus type 1 and 2. Chiron HSV Vaccine Study Group. N Engl J Med 1999, 341:1432-1438.
41. LaVail J.H., Tauscher A.N., Aghaian E., et al. Axonal transport and sorting of herpes simplex virus components in a mature mouse visual system. J Virology 2003, 77:6117-6126.
42. Leib D.A., Coen D.M., Bogard C.L., et al. Immediate-early regulatory gene mutants define different stages in the establishment and reactivation of herpes simplex virus latency. J Virology 1989, 63:759-768.
43. Lewallen S., Chirambo M.C. Herpetic corneal ulcers in Malawi. Br J Ophthalmol 1993, 77:827.
44. Liesegang T.J. Herpes simplex virus epidemiology and ocular importance. Cornea 2001, 20:1-13.
45. Liesegang T.J., Melton L.J., Daly P.J., et al. Epidemiology of ocular herpes simplex: incidence in Rochester, Minn, 1950 through 1982. Arch Ophthalmol 1989, 107:1155-1159.
46. Liesegang T.J. Epidemiology of ocular herpes simplex: natural history in Rochester, Minn, 1950 through 1982. Arch Ophthalmol 1989, 107:1160-1165.
47. Lilley C.E., Carson C.T., Muotri A.R., et al. DNA repair proteins affect the lifecycle of herpes simplex virus 1. Proc Natl Acad Sci 2005, 102:5844-5849.
48. Looker K.J., Garnett G.P., Schmid G.P. An estimate of the global prevalence and incidence of herpes simplex virus 2 infection. Bull World Health Organ 2008, 86:805-812.
49. Malkin J. Epidemiology of genital herpes simplex virus infection in developed countries. Herpes 2004, 11(Suppl 1):2a-23a.
50. Margolis T.P., LaVail J.H., Setzer P.Y., et al. Selective spread of herpes simplex virus in the central nervous system after ocular inoculation. J Virol 1989, 63:4756-4761.
51. Mariotti S.P., Pascolini D., Rose-Nussbaumer J. Trachoma: global magnitude of a preventable cause of blindness. Br J Ophthalmol 2009, 93:563-568.
52. McGraw H.M., Awasthi S., Wojcechowskyj J.A., et al. Anterograde spread of herpes simplex virus type 1 requires glycoprotein E and glycoprotein I but not US9. J Virol 2009, 83:8315-8326.
53. Mertz G.J., Benedetti J., Ashley R., et al. Risk factors for the sexual transmission of genital herpes. Ann Intern Med 1992, 116:197-202.
54. Mets M.B., Chhabra M.S. Eye manifestations of intrauterine infections and their impact on childhood blindness. Surv Ophthalmol 2008, 53:95-111.
55. Miserocchi E., Waheed N.K., Dios E., et al. Visual outcome in herpes simplex virus and varicella zoster virus uveitis: a clinical evaluation and comparison. Ophthalmology 2002, 109:1532-1537.
56. Misson G.P., Landini G., Murray P.I. Size dependent variation in the fractal dimensions of herpes simplex epithelial keratitis. Curr Eye Res 1993, 12:957-961.
57. Morfin F., Thouvenot D. Herpes simplex virus resistance to antiviral drugs. J Clin Virol 2003, 26:29-37.
58. Morris D.J., Cleator G.M., Klapper P.E., et al. Detection of herpes simplex virus DNA in donor cornea culture medium by polymerase chain reaction. Br J Ophthalmol 1996, 80:654-657.
59. Mott K.R., Bresee C.J., Allen S.J., et al. Level of herpes simplex virus type 1 latency correlates with severity of corneal scarring and exhaustion of CD8+ T cells in trigeminal ganglia of latently infected mice. J Virology 2009, 83:2246-2254.
60. Muthiah M.N., Michaelides M., Child C.S., et al. Acute retinal necrosis: a national population-based study to assess the incidence, methods of diagnosis, treatment strategies and outcomes in the UK. Br J Ophthalmol 2007, 91:1452-1455.
61. Nahmias A.J., Visintine A.M., Caldwell D.R., et al. Eye infections with herpes simplex virus in neonates. Surv Ophthalmol 1976, 21:100-105.
62. Nesburn A.B., Burke R.L., Ghiasi H., et al. A therapeutic vaccine that reduces recurrent herpes simplex virus type 1 corneal disease. Invest Ophthalmol Vis Sci 1998, 39:1163-1170.
63. Newell C.K., Martin S., Sendele D., et al. Herpes simplex virus-induced stromal keratitis: role of T-lymphocyte subsets in immunopathology. J Virol 1989, 63:769-775.
64. Norn M.S. Dendritic (herpetic) keratitis. I. Incidence--seasonal variations--recurrence rate--visual impairment--therapy. Acta Ophthalmol (Copenh) 1970, 48:91-107.
65. Pepose J.S., Keadle T.L., Morrison L.A. Ocular herpes simplex: changing epidemiology, emerging disease patterns, and the potential of vaccine prevention and therapy. Am J Ophthalmol 2006, 141:547-557.
66. Perng G., Jones C., Ciacci-Zanella J., et al. Virus-induced neuronal apoptosis blocked by the herpes simplex virus latency-associated transcript. Science 2000, 287:1500-1503.
67. Pivetti-Pezzi P., Accorinti M., Colabeli-Gisoldi R.A., et al. Herpes simplex virus vaccine in recurrent herpetic ocular infection. Cornea 1999, 18:47-51.
68. Polcicova K., Biswas P.S., Banerjee K., et al. Herpes keratitis in the absence of anterograde transport of virus from sensory ganglia to the cornea. Proc Nat Acad Sci 2005, 102:11462-11467.
69. Remeijer L., Duan R., van Dun J.M., et al. Prevalence and clinical consequences of herpes simplex virus type 1 DNA in human cornea tissues. J Infect Dis 2009, 200:11-19.
70. Remeijer L., Maertzdorf J., Doomenbal P., et al. Herpes simplex virus 1 transmission through corneal transplantation. Lancet 2001, 357:442.
71. Reyes M., Shaik N.S., Graber J.M., et al. Acyclovir-resistant genital herpes among persons attending sexually transmitted disease and human immunodeficiency virus clinics. Arch Intern Med 2003, 163:76-80.
72. Robert P., Adenis J., Denis F., et al. Transmission of viruses through corneal transplantation. Clin Lab 2005, 51:419-423.
73. Robert P., Adenis J., Denis F., et al. Herpes simplex virus DNA in corneal transplants: prospective study of 38 recipients. J Med Virol 2003, 71:69-74.
74. Roberts C.M., Pfister J.R., Spear S.J. Increasing proportion of herpes simplex virus type 1 as a cause of genital herpes infection in college students. Sex Transm Dis 2003, 30:797-800.
75. Scoular A. Using the evidence base on genital herpes: optimising the use of diagnostic tests and information provision. Sex Transm Infect 2002, 78:160-165.
76. Shimomura Y., Deai T., Fukuda M., et al. Corneal buttons obtained from patients with HSK harbor high copy numbers of the HSV genome. Cornea 2007, 26:190-193.
77. Srinivasan M., Gonzales C.A., George C., et al. Epidemiology and aetiologic diagnosis of corneal ulceration in Madurai, South India. Br J Ophthalmol 1997, 81:965-971.
78. Stanberry L.R. Clinical trials of prophylactic and therapeutic herpes simplex virus vaccines. Herpes 2004, 11(Suppl 3):161a-169a.
79. Stránská R., Schuurman R., Nienhuis E., et al. Survey of acyclovir-resistant herpes simplex virus in the Netherlands: prevalence and characterization. J Clin Virol 2005, 32:7-18.
80. Sugar J. Infectious disease risk factors of corneal donors: is there new cause for concern?. Arch Ophthalmol 2008, 126:262.
81. Acyclovir for the prevention of recurrent herpes simplex virus eye disease. N Engl J Med 1998, 339:300-306. The Herpetic Eye Disease Study Group.
82. Tiwari V., Shukla S.Y., Yue B.Y., et al. Herpes simplex virus type 2 entry into cultured human corneal fibroblasts is mediated by herpesvirus entry mediator. J Gen Virol 2007, 88:2106-2110.
83. Tuppin P., Poinard C., Loty B., et al. Risk factors for corneal regraft in patients on the French waiting list. Cornea 2004, 23:704-711.
84. Uchio E., Hatano H., Mitsui K., et al. A retrospective study of herpes simplex keratitis over the last 30 years. Jpn J Ophthalmol 1994, 38:196-201.
85. Valyi-Nagy T., Sheth V., Clement C., et al. Herpes simplex virus entry receptor nectin-1 is widely expressed in the murine eye. Curr Eye Res 2004, 29:303-309.
86. van Gelderen B.E., van der Lelij A., Treffer W.F., van der Gaag R. Detection of herpes simplex virus type 1, 2 and varicella zoster virus DNA in recipient corneal buttons. Br J Ophthalmol 2000, 84:1238-1243.
87. van Lint A.L., Torres-Lopez E., Knipe D.M. Immunization with a replication-defective herpes simplex virus 2 mutant reduces herpes simplex virus 1 infection and prevents ocular disease. Virology 2007, 368:227-231.
88. Wald A., Huang M., Carrell D., et al. Polymerase chain reaction for detection of herpes simplex virus (HSV) DNA on mucosal surfaces: comparison with HSV isolation in cell culture. J Infect Dis 2003, 188:1345-1351.
89. Weiss H. Epidemiology of herpes simplex virus type 2 infection in the developing world. Herpes 2004, 11:24A-35A.
90. Wheeler C.E. The herpes simplex problem. J Am Acad Dermatol 1988, 18:163-168.
91. Whitcher J.P., Srinivasan M., Upadhyay M.P. Corneal blindness: a global perspective. Bull World Health Organ 2001, 79:214-221.
92. Wilhelmus K.R. Epidemiology of ocular infections. Duane's Foundations of Clinical Ophthalmology 1998, 1-46. Lippincott Williams & Wilkins, Philadelphia, PA. W. Tasman, E.A. Jaeger (Eds.).
93. Wilhelmus K.R., Coster D.J., Donovan H.C., et al. Prognostic indicators of herpetic keratitis: analysis of a five-year observation period after corneal ulceration. Arch Ophthalmol 1981, 99:1578-1582.
94. Xie L., Zhai H., Dong X., et al. Primary diseases of corneal perforation in Shandong Province, China: a 10-year retrospective study. Am J Ophthalmol 2008, 145:662-666.
95. Xie L., Song Z., Zhao J., et al. Indications for penetrating keratoplasty in north China. Cornea 2007, 26:1070-1073.
96. Xu F., Markowitz L.E., Gottlieb S.L., et al. Seroprevalence of herpes simplex virus types 1 and 2 in pregnant women in the United States. Am J Obstet Gynecol 2007, 196:43.e1-43.e6.
97. Xu F., Sternberg M.R., Kottiri B.J., et al. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA 2006, 296:964-973.
98. Yalniz-Akkaya Z., Nurozler A.B., Yildiz E.H., et al. Repeat penetrating keratoplasty: indications and prognosis, 1995-2005. Eur J Ophthalmol 2009, 19:362-368.
99. Yorston D., Foster A. Corneal ulceration in Tanzanian children: relationship between malaria and herpes simplex keratitis. T Roy Soc Trop Med H 1992, 86:456-457.
100. Yorston D., Foster A. Herpetic keratitis in Tanzania: association with malaria. Br J Ophthalmol 1992, 76:582-585.
101. Young T.L., Robin J.B., Holland G.N., et al. Herpes simplex keratitis in patients with acquired immune deficiency syndrome. Ophthalmology 1989, 96:1476-1479.
102. Zheng X. Reactivation and donor-host transmission of herpes simplex virus after corneal transplantation. Cornea 2002, 21(Suppl 7):S90-S93.
103. Zwaagstra J.C., Ghiasi H., Nesburn A.B., et al. Identification of a major regulatory sequence in the latency associated transcript (LAT) promoter of herpes simplex virus type 1 (HSV-1). Virology 1991, 182:287-297.